Intrathecal administration of thiorphan, bestatin, desipramine and fluoxetine differentially potentiate the antinociceptive effects induced by β-endorphin and morphine, administered intracerebroventricularly

This publication has 31 references indexed in Scilit:

• Evidence that endogenous enkephalins and a δ opioid receptor agonist have a common site of action in spinal antinociception
  European Journal of Pharmacology, 1988
• The Inactivation of [Met5]-Enkephalin by Bestatin-Sensitive Aminopeptidase, Captopril-Sensitive Peptidyl Dipeptidase A and Thiorphan-Sensitive Endopeptidase-24.11 in Mouse Vas Deferens
  The Japanese Journal of Pharmacology, 1986
• II. Examination of spinal monoamine receptors through which brainstem opiate-sensitive systems act in the rat
  Brain Research, 1986
• The Relative Potency of Enkephalins and β-Endorphin in Guinea-Pig Ileum, Mouse Vas Deferens and Rat Vas Deferens after the Administration of Peptidase Inhibitors
  The Japanese Journal of Pharmacology, 1986
• Fluoxetine, a selective inhibitor of serotonin uptake, potentiates morphine analgesia without altering its discriminative stimulus properties or affinity for opioid receptors
  Life Sciences, 1985
• Separate involvement of the spinal noradrenergic and serotonergic systems in morphine analgesia: the differences in mechanical and thermal algesic tests
  Brain Research, 1983
• Intrathecal morphine in mice: A new technique
  European Journal of Pharmacology, 1980
• Noradrenaline regulation of pain-transmission in the spinal cord mediated by α-adrenoceptors
  Brain Research, 1979
• A double-blind controlled study of a serotonin uptake inhibitor (Zimelidine) versus placebo in chronic pain patients
  Pain, 1979
• Microinjection of opioids into the nucleus reticularis gigantocellularis of the rat: Analgesia and increase in the normetanephrine level in the spinal cord
  Biochemical Pharmacology, 1978